Investment Rating - The report maintains an "Overweight" rating for both the Utilities and Environmental sectors [6]. Core Viewpoints - The report emphasizes that the environmental value of green electricity is being re-evaluated due to the impending hard constraints of the Nationally Determined Contributions (NDC) by 2035, shifting China's climate action from intensity control to total reduction [16]. - It predicts that the demand for green electricity will not be less than 6.59 trillion kWh by 2035, with an average annual increase in wind and solar installations of 4.15 million kW from 2026 to 2035, significantly higher than the average of 2.61 million kW during the 14th Five-Year Plan [7][46]. - The report identifies three main lines of opportunity: benefiting green electricity operators and leading energy-intensive companies through direct connections to green electricity, the importance of green electricity self-sufficiency for energy-intensive leaders, and the potential of the green fuel sector under total reduction policies [5][6]. Summary by Sections Investment Recommendations - Recommended stocks include: - Longking Environmental (600388 CH) with a target price of 28.96 and a "Buy" rating - China Power (2380 HK) with a target price of 3.86 and a "Buy" rating - Three Gorges Energy (600905 CH) with a target price of 4.75 and a "Buy" rating - Longyuan Power (001289 CH) with a target price of 19.44 and a "Buy" rating [3]. Market Perspective - The report contrasts with market consensus, which views NDC as a long-term concept with limited short-term impact. It argues that the countdown to carbon peak from 2028 to 2030 is only 2-4 years away, making NDC a potential annual assessment constraint [4][13]. - It highlights that the supply-demand dynamics for green certificates have reversed, with a significant increase in demand expected by 2030, reaching 3-3.3 billion certificates [14]. Policy Impact - The report notes that policies have reshaped the supply-demand structure for green certificates, with a significant reduction in effective supply due to new regulations [8]. - It predicts that the price of green certificates could double, significantly enhancing the revenue for green electricity operators and reconstructing the valuation framework for the sector [6][9]. Carbon Emission Projections - The report estimates that carbon emissions will peak between 11.4 and 11.8 billion tons CO₂e from 2028 to 2030, with a projected reduction of 7.2% to 8.4% by 2035 compared to peak levels [19][21]. - It emphasizes that coal consumption will peak during the same period, while natural gas consumption is expected to rise [32][37]. Green Electricity Demand - The report asserts that the actual demand for green electricity will exceed expectations, with a projected total capacity of 36 billion kW by 2035, which is only the baseline requirement [46]. - It anticipates that the cumulative increase in wind and solar installations could reach 415 million kW over the decade from 2026 to 2035, with a compound annual growth rate of 13.8% [46].

Investment Rating - The investment rating for MGM China is maintained as "Buy" with a target price of HKD 18.20 [2][9]. Core Insights - MGM China reported strong performance in its mid-to-high-end business, with a market share increase to 16.5% in Q4 2025 and 16.1% for the full year, marking a historical high [5]. - The company achieved operating revenue of HKD 96.2 billion for Q4 2025 and HKD 347.9 billion for the full year, reflecting a year-on-year increase of 21% and 10.8%, respectively [5]. - Adjusted EBITDA for Q4 2025 and the full year reached HKD 27.5 billion and HKD 100 billion, with year-on-year growth of 29% and 10.4% [5]. Financial Projections and Valuation - Revenue projections for MGM China are as follows: - 2025: HKD 34,788 million - 2026E: HKD 35,657 million (+2.31%) - 2027E: HKD 36,727 million (+3.83%) - 2028E: HKD 37,645 million (+3.30%) [4]. - Net profit attributable to the parent company is projected to be: - 2025: HKD 5,075 million - 2026E: HKD 5,242 million (+3.29%) - 2027E: HKD 5,399 million (+3.00%) - 2028E: HKD 5,571 million (+3.19%) [4]. - The expected PE ratio for 2026 is 7.86, and the expected dividend yield is 3.46% [4]. Business Performance - The mid-market gross gaming revenue (GGR) increased by 10.2% to HKD 315.1 billion, driven by strong betting volumes at MGM Cotai and MGM Macau [6]. - VIP GGR rose by 19.5% to HKD 48.4 billion, although there was a decline in VIP customer traffic and betting intentions [6]. - Slot machine revenue saw a slight increase of 3.3% to HKD 23.0 billion, despite a drop in overall win rates [6]. Strategic Initiatives - MGM China is deepening its "Tourism+" strategy to enhance brand loyalty among high-end customers, including the launch of new luxury offerings and entertainment projects [8]. - The company plans to leverage its parent company's global sales platform to accelerate the expansion of international customer sources [8]. Earnings Forecast Adjustments - The EBITDA forecast for 2026 and 2027 has been raised by 8% to HKD 97.3 billion and HKD 101.0 billion, respectively, with an introduction of a new EBITDA forecast for 2028 at HKD 103.5 billion [9].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of RMB 37.29 per share [7][5]. Core Insights - The company achieved a revenue of RMB 41.241 billion in 2025, representing a year-over-year increase of 7.47%, while the net profit attributable to shareholders was RMB 4.005 billion, down 7.00% year-over-year [1][2]. - The company is expected to benefit from a dual increase in profits from both electrolytic aluminum and coal, as coal prices are anticipated to stabilize and rise, alongside high aluminum prices [1][4]. - The report highlights that the company has reached full production capacity for the first time in 2025, producing 7.1653 million tons of coal and selling 7.2168 million tons, achieving a sales completion rate of 100.23% [2]. Financial Performance - The gross profit margin for 2025 was 23.36%, an increase of 2.13 percentage points year-over-year, with specific margins for electrolytic aluminum and coal products at 30.06% and 7.61%, respectively [2]. - The company reported an asset impairment loss of RMB 1.256 billion in 2025, primarily due to impairment provisions for certain coal mine assets [2]. - The forecast for net profit attributable to shareholders is adjusted to RMB 8.364 billion, RMB 9.185 billion, and RMB 9.300 billion for 2026, 2027, and 2028, respectively, reflecting a compound annual growth rate of 32.42% [5][11]. Market Dynamics - The global supply of electrolytic aluminum is nearing its capacity ceiling, with future growth expected to rely on overseas production, particularly impacted by geopolitical tensions in the Middle East [3]. - The report estimates that the global demand for aluminum will grow at approximately 1.53% in 2026, while the supply may only increase by 1.18%, leading to a projected supply gap of 659,600 tons [3]. - The report anticipates that aluminum prices may rise to around USD 4,000 per ton as market sentiment stabilizes [3]. Production Capacity and Cost Structure - As of December 31, 2025, the company has an electrolytic aluminum production capacity of 1.7 million tons, with low-cost advantages from its coal and hydropower bases [4]. - The average mining price for coal in 2025 was RMB 1,023.6 per ton, down 21.6% year-over-year, indicating potential for cost advantages in the upcoming years [4]. Valuation Metrics - The report provides a valuation of the company with a price-to-earnings ratio (PE) of 9.6x for the electrolytic aluminum segment and 16.0x for the coal segment for 2026, maintaining a cautious outlook due to macroeconomic risks [5][11].

Investment Rating - The investment rating for the company is "Buy" with a target price of HKD 22.53 [1][5] Core Views - The company reported a revenue of RMB 575.2 billion for 2025, a decrease of 1.6% year-on-year, and a net profit of RMB 7.16 billion, an increase of 1.5% year-on-year, which aligns with market expectations. The revenue and profit growth showed marginal improvement compared to the first three quarters of 2025, primarily due to resilient performance in the pharmaceutical and medical device distribution sectors, as well as effective cost control measures [1][5] - For 2026, the company is expected to maintain positive net profit growth, driven by continued structural optimization in pharmaceutical and medical device distribution and improved operational efficiency in retail [1] Summary by Sections Pharmaceutical Distribution - The pharmaceutical distribution segment generated revenue of RMB 435.4 billion in 2025, down 2.02% year-on-year, with an operating profit margin of 2.73%, remaining stable compared to the previous year. The outlook for 2026 is optimistic, supported by ongoing optimization of product categories and strengthening direct sales to high-tier hospitals and retail terminals [2] Medical Device Distribution - The medical device distribution segment reported revenue of RMB 115.5 billion in 2025, also down 2.02% year-on-year, primarily due to intensified procurement policies. The segment is expected to benefit from structural adjustments in 2026, including enhanced management of payment terms and an increased focus on high-value-added businesses [3] Retail Business - The retail business achieved revenue of RMB 38.4 billion in 2025, a growth of 6.67% year-on-year, becoming the leading growth segment for the company. The operating profit margin improved to 1.56%, driven by cost control measures and a significant reduction in losses for the Guoda Pharmacy [4] Profit Forecast and Valuation - The company is projected to have an EPS of RMB 2.50, RMB 2.71, and RMB 2.89 for the years 2026, 2027, and 2028 respectively. The target price remains at HKD 22.53, based on an 8.2x PE ratio for 2026, which is in line with comparable companies [5][10]

Investment Rating - The investment rating for the company is maintained at "Buy" [1] Core Views - The company reported a revenue of 36.874 billion RMB for 2025, a decrease of 20% year-on-year, and a net profit attributable to shareholders of 304.66 million RMB, down 68% year-on-year, slightly below the previous expectation of 327 million RMB [1] - The decline in performance is attributed to reduced revenue recognition from development projects, increased sales expenses, and impairment losses, but the company’s projects are located in core areas of lower-tier cities, which helps maintain sales velocity and profit margins [1][2] - The company has a total gross value of new projects of 92.9 billion RMB with an average expected gross margin of 19%, significantly higher than the reported gross margin for 2024-2025 [2] Financial Performance - The company’s equity sales amount to 28 billion RMB in 2025, a decrease of 18% year-on-year, which is slightly higher than the national average decline of 13% [3] - The company’s land acquisition amount reached 11.7 billion RMB, an increase of 124% year-on-year, with an equity acquisition intensity rising by 22 percentage points to 36.6% [3] - As of the end of 2025, the company’s debt-to-asset ratio decreased by 1.6 percentage points to 61.4%, and the net debt ratio decreased by 1.4 percentage points to 31.7% [4] Profit Forecast and Valuation - The forecast for net profit attributable to shareholders for 2026 and 2027 has been revised down by 34% and 47% to 289 million RMB and 304 million RMB respectively, with an expected net profit of 348 million RMB for 2028 [5] - The estimated earnings per share (EPS) for 2026, 2027, and 2028 are projected to be 0.08, 0.09, and 0.10 RMB respectively [5] - The company’s price-to-book (PB) ratio is estimated at 0.25x for 2026, reflecting a discount of 10% compared to comparable companies [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) for both A-shares and H-shares [7]. Core Insights - The company reported a revenue of 45.456 billion RMB for 2025, representing a year-over-year increase of 15.84%. The net profit attributable to shareholders was 19.151 billion RMB, up 102.65% year-over-year, and the adjusted non-IFRS net profit was 14.957 billion RMB, reflecting a 41.33% increase [1][5]. - The company expects a revenue growth guidance of 18-22% for 2026, supported by a strong order backlog and anticipated acceleration in growth for 2026-2027 [2][3]. - The TIDES business segment is projected to maintain high growth, with a revenue of 36.47 billion RMB in 2025, marking a 25.5% year-over-year increase, driven by a significant rise in orders and customer engagement [3][4]. Summary by Sections Financial Performance - For 2025, the company achieved a revenue of 45.456 billion RMB, with a net profit of 19.151 billion RMB, and an adjusted non-IFRS net profit of 14.957 billion RMB [1][5]. - The company anticipates revenues of 51.3-53 billion RMB for 2026, with a continued focus on maintaining a stable adjusted non-IFRS net profit margin [2]. Business Segments - WuXi Chemistry's revenue for 2025 is expected to reach 36.47 billion RMB, with a non-IFRS gross margin of 52.3%, driven by the TIDES segment's growth [3]. - The WuXi Testing and WuXi Biology segments are projected to stabilize, with revenues of 4.04 billion RMB and 2.68 billion RMB respectively for 2025, and expected growth rates of around 10% for 2026 [4]. Valuation and Estimates - The company is valued at 334.81 billion RMB for A-shares and 381.7 billion HKD for H-shares, with a target price of 112.21 RMB and 127.93 HKD respectively [5][12]. - The earnings per share (EPS) estimates for 2026, 2027, and 2028 are projected to be 5.66 RMB, 6.72 RMB, and 7.88 RMB respectively, reflecting an upward adjustment due to better-than-expected growth in the TIDES segment [5][11].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 100.70 [7][16]. Core Insights - The company achieved its first quarterly profit in Q4 2025, with a revenue of RMB 223 billion, a year-on-year increase of 38%, and a net profit of RMB 3.8 billion, marking a turnaround from losses [1][2]. - The overall gross margin improved to 21.3% in Q4 2025, driven by enhanced scale effects, new model launches, and high-margin service contributions [2][3]. - The company plans to launch four new models in 2026, including a flagship SUV and three Robotaxi models, which are expected to drive revenue growth [3][4]. Financial Performance - In 2025, the company reported a total revenue of RMB 767 billion, an 88% increase year-on-year, and a reduced net loss of RMB 11 billion, down 80% from the previous year [1][11]. - The Q4 2025 sales volume reached 116,249 units, a 27% increase year-on-year, with a gross margin improvement of 1.2 percentage points from the previous quarter [2][21]. - The company forecasts revenues of RMB 1,036 billion for 2026, RMB 1,305 billion for 2027, and RMB 1,678 billion for 2028 [5][11]. Valuation and Estimates - The report employs a segmented valuation approach, estimating the automotive sales business at 0.95x 2026E PS, with a total valuation of approximately RMB 892 billion [5][13]. - The Robotaxi business is valued at RMB 233 billion, while the humanoid robot business is estimated at RMB 360 billion [5][15]. - The overall market capitalization is projected to be around RMB 1,693 billion, leading to a target price of HKD 100.70 [16][20].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 100.70 [7][16]. Core Insights - The company achieved its first quarterly profit in Q4 2025, with a revenue of RMB 223 billion, representing a 38% year-on-year increase and a net profit of RMB 3.8 billion, marking a turnaround from losses [1][2]. - The report highlights the company's strong performance driven by scale effects, improved high-margin services, and carbon credit contributions, projecting continued growth in 2026 due to its dual-energy vehicle product matrix and advancements in Robotaxi and AI driving capabilities [1][3]. Financial Performance - In Q4 2025, the company sold 116,000 new vehicles, a 27% year-on-year increase, with an overall gross margin of 21.3%, up 6.9 percentage points year-on-year [2][21]. - The report forecasts revenues of RMB 1,036 billion for 2026, RMB 1,305 billion for 2027, and RMB 1,678 billion for 2028, with a significant improvement in net profit expected [5][11]. Vehicle and Product Development - The company plans to launch four new models in 2026, including a flagship large SUV and three Robotaxi models, which are expected to enhance profitability and market presence [3][4]. - The introduction of the VLA 2.0 technology and self-developed Turing chips is anticipated to accelerate the commercialization of AI applications in vehicles and robots [4][5]. Valuation and Market Position - The report employs a segmented valuation approach, estimating the automotive sales business at 0.95x 2026E PS, with a total estimated market value of approximately RMB 1,693 billion [5][16]. - The Robotaxi business is valued at RMB 233 billion, while the humanoid robot business is estimated at RMB 360 billion, reflecting the company's competitive positioning in the market [5][15].

Investment Rating - The investment rating for the company is "Buy" (maintained) for both A-shares and H-shares [7]. Core Views - The company reported a revenue of 45.456 billion RMB for 2025, representing a year-over-year increase of 15.84%. The net profit attributable to shareholders was 19.151 billion RMB, up 102.65% year-over-year, and the adjusted non-IFRS net profit was 14.957 billion RMB, reflecting a 41.33% increase [1][5]. - The company expects a revenue growth guidance of 18-22% for its continuing operations in 2026, supported by a strong order backlog [2][3]. - The TIDES business segment is projected to maintain high growth, with a revenue increase of 96.0% year-over-year in 2025, contributing significantly to the overall revenue growth [3][4]. Summary by Sections Financial Performance - In Q4 2025, the company achieved a revenue of 12.599 billion RMB, a 9.19% increase year-over-year, and a net profit of 7.075 billion RMB, up 142.52% year-over-year [1]. - The gross margin for 2025 improved by 6.2 percentage points year-over-year, driven by a higher proportion of high-margin revenue [1]. Business Segments - WuXi Chemistry's revenue for 2025 was 36.47 billion RMB, with an adjusted non-IFRS gross margin of 52.3%, indicating a strong performance in the small molecule CDMO and TIDES segments [3]. - The WuXi Testing and WuXi Biology segments are expected to stabilize, with projected revenue growth rates of around 10% and high single-digit growth, respectively, in 2026 [4]. Profitability and Valuation - The company’s projected net profits for 2026-2028 are 16.887 billion RMB, 20.065 billion RMB, and 23.517 billion RMB, respectively, with corresponding EPS estimates of 5.66 RMB, 6.72 RMB, and 7.88 RMB [5][11]. - The company is valued at 334.81 billion RMB for A-shares and 381.70 billion HKD for H-shares, with target prices set at 112.21 RMB and 127.93 HKD, respectively [5][12].

Investment Rating - The investment rating for China Overseas Macro Yang Group is maintained at "Buy" with a target price of HKD 2.51 [1][5] Core Views - The company reported a revenue of RMB 36.874 billion for 2025, a decrease of 20% year-on-year, and a net profit attributable to shareholders of RMB 305 million, down 68% year-on-year, slightly below the previous expectation of RMB 327 million [1][2] - Despite the decline in revenue and profit, the company has projects located in core areas of lower-tier cities, which can help maintain sales velocity and profit margins. The expectation is that as high-margin projects are gradually recognized, the company's performance may improve [1][2] - The company has seen a significant increase in land acquisition, with a total land acquisition amount of RMB 11.7 billion, up 124% year-on-year, indicating a strong investment intensity [3][4] Summary by Sections Financial Performance - The gross profit margin slightly improved, with the net profit margin decreasing by 1.25 percentage points to 0.83% [2] - The company’s debt ratios have improved, with the asset-liability ratio decreasing by 1.6 percentage points to 61.4% and the net debt ratio down by 1.4 percentage points to 31.7% [4] Sales and Marketing - The company’s equity sales amount to RMB 28 billion, down 18% year-on-year, which is a larger decline than the national average of 13% [3] - The sales expense ratio increased by 0.5 percentage points to 3.5% as the company intensified marketing efforts to promote sales [2] Future Outlook - The company’s new projects from 2022 to 2025 have a total value of RMB 92.9 billion, with an expected average gross profit margin of 19%, significantly higher than the reported gross profit margin for 2024-2025 [2] - The forecast for net profit attributable to shareholders for 2026 and 2027 has been revised down by 34% and 47% to RMB 289 million and RMB 304 million, respectively, with an expected EPS of RMB 0.08 and RMB 0.09 [5][14]